Skip to main content
. 2021 Oct 11;7(4):00074-2021. doi: 10.1183/23120541.00074-2021

TABLE 1.

Subject demographics and baseline spirometry

Healthy Asthma COPD
N 15 (4 male) 15 (6 male) 15 (10 male)
Age (years) 30.3±8.5 57.2±21.2** 71.4±9.2****
BMI (kg·m−2) 23.1±2.5 27.1±4.7* 26.2±6.3
Smoking history (never/current/ex) 13/1/1 12/1/2 0/3/12
Smoking history (pack-years)# 0 (0, 0) 0 (0, 0.25) 40 (28, 77)****,####
GOLD stages (I/II/III/IV) 6/5/4/0
Pre-BD FEV1 (%) 96.6±12.1 90.2±20.0 59.5±21.1****,###
Pre-BD FVC (%) 99.3±9.9 110.9±21.3 90.5±17.8##
Pre-BD FEV1/FVC 82.3±7.2 65.4±8.1*** 49.6±13.8****,###
Post-BD FEV1 (%) 88.7±20.0 67.0±24.1#
Post-BD FVC (%) 105.0±18.0 94.0±18.5
Post-BD FEV1/FVC 66.3±8.6 52.1±15.1##

Data are presented as mean±sd or median (interquartile range), unless otherwise stated. BMI: body mass index; GOLD: Global Initiative for Chronic Obstructive Lung Disease; BD: bronchodilator; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity. *: p<0.05; **: p<0.01; ***: p<0.001; ****: p<0.0001 compared with healthy controls; #: p<0.05; ##: p<0.01; ###: p<0.001; ####: p<0.0001 compared with asthma.